To describe 5-year mortality after status epilepticus (SE) and identify factors associated with long-term survival. We also validated the prognostic performance of the Age, Consciousness, Duration (ACD) score and evaluated long-term survival across etiological categories defined by the Lattanzi classification of acute symptomatic SE.
Methods
Retrospective cohort analysis of a prospectively maintained database of consecutive patients ≥16 years of age with confirmed SE admitted to a tertiary epilepsy center (2011-2022). We excluded unclear diagnoses, hypoxic-anoxic etiologies, and incomplete follow-up. We recorded clinical variables and prognostic scores modified Status Epilepticus Severity Score (mSTESS), Epidemiology-based Mortality Status Epilepticus (EMSE), and Age, Consciousness, Duration (ACD). Mortality was assessed at discharge and annually up to 5 years.
Results
We included 786 patients (mean age 63.4 years, 43.5% female). Five-year mortality was 50.3%, with 44.0% of deaths occurring within the first 2 years. Neurological causes accounted for 60.8% of deaths, and direct seizure-related causes represented 74.6% of neurological deaths. Independent predictors of higher long-term mortality were older age, higher premorbid mRS, absence of prior seizure history, comorbidity burden, systemic complications, and impaired consciousness during SE; convulsive and focal motor SE were associated with lower mortality risk. mSTESS and EMSE were associated with long-term mortality. In patients with less damaging etiologies, ACD predicted 5-year mortality (hazard ratio [HR] 1.163, 95% confidence interval [CI] 1.063-1.273; area under the curve [AUC] 0.717); ACD ≥10 corresponded to >50% 2-year mortality. Five-year mortality was 61.3% (acute-primary Central Nervous System (CNS) and 58.3% (acute-secondary CNS).
Significance
SE carries substantial long-term mortality, particularly within the first 2 years. Neurological and seizure-related causes were the most frequent. The Lattanzi classification and the ACD score retained long-term prognostic value.
The ACARD score is a user-friendly tool developed to predict 30-day mortality after nonhypoxic SE and has the potential to identify participants at high risk of short-term mortality and outperform the performance of other available scoring systems.
Simona Lattanzi, E. Trinka, P. Bosque-Varela et al.· Neurology· 0 citations
Findings underscore the prognostic importance of ASyS as a clinical indicator of increased long-term mortality, particularly in medically complex patients.
Melissa S. Murphy, E. Maloney, Jessica Stack et al.· Neurology Clinical Practice· 0 citations
Undocumented latency to BZD administration and acute symptomatic etiology were independently associated with RSE, highlighting challenges of timely SE recognition and supporting efforts to standardize treatment pathways in resource-limited settings.
D. Rivero Rodríguez, Y. Pernas Sanchez, D. Dicapua Sacoto et al.· Epilepsy & Behavior· 0 citations
High-frequency IEDs on early postoperative EEG may identify patients at increased risk of long-term deterioration after surgery for HS-related TLE, and prospective studies are needed before modifying routine follow-up strategies.
Kate Durbano, Q. Calonge, V. Frazzini et al.· Seizure· 0 citations
Real-world insights into RSE in a resource-limited setting are offered, highlighting preventable causes, management complexity, and high care demands, and favorable outcomes are often achievable.
Jocelyn Cruz-Pérez, J. Zepeda-Pérez, E. Z. Camacho-Castillo et al.· Neurocritical Care· 0 citations
The STEPSS >2 shows a moderate predictive performance of functional outcomes in children with SE at discharge and at 3-month follow-up, with clinically useful sensitivity and specificity.
Sai Anjali Kambala, S. Sindgikar· International Journal of Epi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.